DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Schneeweiss A, Chia S, Hickish T. et al.
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early
breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Ann Oncol 2013;
24: 2278-2284
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.